ALVO · NASDAQ · Drug Manufacturers - Specialty & Generic

Alvotech (ALVO)

Develops and manufactures biosimilar medicines through an integrated platform and partner network.

$5.76
vs last close−0.08 (−1.46%)
  1. Alvotech Q2 Earnings Call Highlights

    MarketBeatEarnings

  2. Alvotech (ALVO) Reports Q2 Loss, Beats Revenue Estimates

    Zacks Investment ResearchEarnings